Future Market Insights (FMI) has released an extensive analysis of the global protein A resins market, highlighting its impressive growth trajectory. According to the report, the United Kingdom protein A resins market is expected to account for nearly 24.1% of the European market by 2033, indicating the region’s critical role in this expanding sector.
The global protein A resins market, valued at USD 677.84 million in 2023, is set to nearly double in value, reaching approximately USD 1,477.01 million by 2033. This growth represents a substantial compound annual growth rate (CAGR) of 8.1%, driven by increasing demand for protein purification processes across various industries, including biotechnology, pharmaceuticals, and diagnostics.
Key factors contributing to this remarkable growth include:
- Rising Biopharmaceutical Production: The surge in biopharmaceutical production, particularly monoclonal antibodies, necessitates advanced purification techniques, fueling the demand for protein A resins.
- Technological Advancements: Innovations in resin technology and manufacturing processes are improving the efficiency and effectiveness of protein purification, further propelling market growth.
- Growing Research Activities: The increasing focus on research and development in biotechnology and life sciences is driving the need for high-quality purification solutions.
- Regulatory Support: Favorable regulatory frameworks and government initiatives in the UK and Europe to support biopharmaceutical manufacturing are creating a conducive environment for market expansion.
“With the UK poised to capture a significant share of the European protein A resins market, we expect to see substantial investments and advancements in this sector,” said at Future Market Insights. “Our projections underscore the critical role of protein A resins in enabling biopharmaceutical innovations and improving therapeutic outcomes.”
As the market continues to evolve, stakeholders, including manufacturers, researchers, and investors, are encouraged to explore opportunities within the protein A resins landscape to capitalize on the projected growth and enhance their competitive positioning.
Growing Need for Market Insights: Access Our Full Report for Thorough Analysis and Trends!
Top Highlights from the FMI’s Analysis of the Protein A Resins Market:
- The United States protein A resins industry is expected to acquire more than 93.5% value share of the North America market.
- Within Europe, the United Kingdom protein A resins industry is expected to take 24.1% of the pie in 2033.
- The China market is anticipated to enlarge at a CAGR of 9.8% over the upcoming years.
- High demand for natural protein A resin is expected to yield a large market share in 2023.
- Under the matrix category, the agarose-composed matrix of protein A resins is expected to record 85.8% of the market share in 2023.
- The antibody purification segment is projected to gain 74.8% of the global market.
- The biopharmaceutical manufacturers segment is expected to emerge as the chief end user of the market, gaining as high as 79.2% of the market in 2023.
Key Players in the Market are:
- GE Healthcare
- Thermo Fisher Scientific
- Kaneka Corporation,
- JNC Corporation
- Purolite Life Sciences
- Bio-Rad Laboratories, Inc.
- JSR Corporation (JSR Life Sciences LLC)
- Repligen
- Tosoh Bioscience, Merck Group (Merck Millipore)
- Novasep Holdings SAS, Agilent Technologies, Inc.
- GenScript, Abcam PLC (Expedeon Ltd.)
- Avantor Inc.
- Takara Bio, PerkinElmer, Inc.
- Suzhou Nanomicro Technology Co., Ltd
Protein A Resins Market by Category:
Product:
- Natural Protein A Resin
- Recombinant Protein A Resin
Matrix:
- Agarose-based Matrix
- Glass or Silica-based Matrix
- Organic Polymer-based Matrix
Application:
- Immunoprecipitation
- Antibody Purification
End User:
- Biopharmaceutical Manufacturers
- Clinical Research Laboratories
- Academic Institutes
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
